Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyman Muss

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342Eric P Winer, Donald A Berry, Susan Woolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physiciansJeanne S Mandelblatt, Vanessa B Sheppard, Arti Hurria, et al.
The New England Journal of Medicine|June 7, 2016
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 YearsPaul E Goss, James N Ingle, Kathleen I Pritchard, et al.
Cancer Discovery|December 17, 2016
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer RelapseMarco Demaria, Monique N O'Leary, Jianhui Chang, et al.
Journal of the American Geriatrics Society|August 28, 2018
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast CancerArti Hurria, Enrique Soto-Perez-de-Celis, Jacob B Allred, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735Stephen Jones, Frankie Ann Holmes, Joyce O'Shaughnessy, et al.
Breast Cancer Research and Treatment|June 26, 2018
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastasesAmanda E D Van Swearingen, Marni B Siegel, Allison M Deal, et al.
Journal for Immunotherapy of Cancer|February 5, 2022
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancerCarey K Anders, Mark G Woodcock, Amanda E D Van Swearingen, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342Eric P Winer, Donald A Berry, Susan Woolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physiciansJeanne S Mandelblatt, Vanessa B Sheppard, Arti Hurria, et al.
The New England Journal of Medicine|June 7, 2016
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 YearsPaul E Goss, James N Ingle, Kathleen I Pritchard, et al.
Cancer Discovery|December 17, 2016
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer RelapseMarco Demaria, Monique N O'Leary, Jianhui Chang, et al.
Journal of the American Geriatrics Society|August 28, 2018
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast CancerArti Hurria, Enrique Soto-Perez-de-Celis, Jacob B Allred, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735Stephen Jones, Frankie Ann Holmes, Joyce O'Shaughnessy, et al.
Breast Cancer Research and Treatment|June 26, 2018
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastasesAmanda E D Van Swearingen, Marni B Siegel, Allison M Deal, et al.
Journal for Immunotherapy of Cancer|February 5, 2022
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancerCarey K Anders, Mark G Woodcock, Amanda E D Van Swearingen, et al.
Pageof 7